Sinopharm

Sinopharm’s China TCM buyout bid lapses without regulatory nods

CHINA National Pharmaceutical Group’s latest attempt to take China Traditional Chinese Medicine (TCM) Holdings private has fallen through as it was unable to secure necessary regulatory approval from ...

Sinopharm, the parent of China-TCM, already holds a 32.46 per cent stake in China-TCM and has offered to pay HK$4.6 (S$0.79) per share in cash to buyout the drugmaker.

Companies & Markets

Sinopharm offers to take China-TCM private in nearly US$3 billion deal

A consortium led by state-owned pharma giant Sinopharm has revived a take-private bid for China Traditional Chinese Medicine Holdings, the Hong-Kong-listed drugmaker said on Wednesday (Feb 21), valuin...

Latest T-bills Treasury Bills Results & Interest News Latest SSB Singapore Savings Bonds News Latest COE Certificate of Entitlement News

Latest Johor-Singapore SEZ News Latest BTO Build To Order & Sales of Balance News Latest STI Straits Times Index News Latest SGX Dividends, Share Price News Latest Bonds Market News Latest Singapore Stocks To Buy News Latest Singapore Economy News